Skip to content

Evommune EVMN Other operating expenses

Other operating expenses at other companies

Bausch + Lomb logo
Bausch + LombBLCO
-$26M-18.2%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$61.26M+52.1%
Hims & Hers Health logo
Hims & Hers HealthHIMS

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+39.5%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's other operating expenses?
Evommune (EVMN) reported other operating expenses of $1.64M in Q1 2026.
How has Evommune 's other operating expenses changed year-over-year?
Evommune 's other operating expenses increased by 82.9% year-over-year, from $898.86K to $1.64M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.